Zacharon Pharmaceuticals, Inc.

San Diego, CA

Zacharon Pharmaceuticals, Inc. is leveraging unique glycobiology expertise to develop an entirely new class of human therapeutics targeting glycans, the carbohydrate portions of glycoproteins, proteoglycans, and glycolipids. Glycans provide attractive targets for a variety of human diseases including lysosomal storage diseases, oncology, inflammation, and others. To unlock this potential, Zacharon created an innovative glycan-targeted drug development platform, a technology breakthrough enabling a new class of human therapeutics addressing substantial unmet needs.